Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ATD 001

Next Previous
Drug Profile

ATD 001

Alternative Names: [18F]PARPi; ATD-001; F-18 PARP; THG 008

Latest Information Update: 16 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Memorial Sloan-Kettering Cancer Center
  • Developer Ariceum Therapeutics; Memorial Sloan-Kettering Cancer Center
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Poly(ADP-ribose) polymerase 2 inhibitors; Poly(ADP-ribose) polymerase-1 inhibitors; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Head and neck cancer

Most Recent Events

  • 16 Oct 2024 Phase I clinical development for ATD 001 is underway in United Kingdom and USA (Ariceum Therapeutics pipeline, October 2024)
  • 28 Mar 2024 No recent reports of development identified for phase-I development in Head-and-neck-cancer(Diagnosis) in United Kingdom (Parenteral, Injection)
  • 01 Jun 2023 Theragnostics has been acquired and merged into Ariceum Therapeutics

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top